ÂÜÀòÂÒÂ×

Ms. Gina Consylman brings over 25 years of experience in finance, accounting, investor relations, strategy, and corporate development to Vedere. Before joining Vedere, Gina served as CFO of bluebird bio where she oversaw financial activities during the company’s transition into two independent entities. Prior to bluebird bio, she spent more than seven years at Ironwood Pharmaceutics, Inc., in roles of increasing responsibilities, culminating in the role of SVP, Chief Financial Officer. There, she was responsible for driving financial strategy through early to late-stage clinical evaluation and commercialization of multiple drug product candidates and products, as well as navigating multiple high-value collaborations with pharmaceutical companies. Gina was also Vice President, Corporate Controller and Principal Accounting Officer at Analogic Corporation, where she oversaw the company’s global accounting team. Additionally, she served as Senior Director of Corporate Accounting at Biogen Inc., where she led the accounting teams for the corporate and U.S. commercial business units. Gina currently serves on the board of directors for Assembly Biosciences, Inc., and holds a B.S. in accounting from Johnson & Wales University and a M.S. in taxation from Bentley University.